Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted EBT Margin of 41.75% for Q2 2026, little changed on a QoQ basis from 41.95% in Q1 2026, and down 153.0% year-over-year from 78.77% in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported EBT Margin for 18 years, with the latest figure at 41.75% in Q2 2026.
- On a quarterly basis, EBT Margin fell 153.0% year-over-year to 41.75% in Q2 2026; TTM through Jun 2026 was 41.9%, a 360.0% increase from a year earlier, with the FY2025 full-year figure at 38.69%, up 3643.0% from the prior year.
- EBT Margin was 41.75% for Q2 2026 at Vertex Pharmaceuticals, roughly flat from 41.95% in the prior quarter.
- The five-year high for EBT Margin was 50.4% in Q3 2022, with the low at 128.18% in Q2 2024.
- Average EBT Margin over 5 years is 33.69%, with a median of 43.72% recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: EBT Margin tumbled 17477 bps in 2024, then soared 17146 bps in 2025.
- Over 5 years, EBT Margin stood at 46.76% in 2022, then declined by 3 bps to 45.58% in 2023, then fell by 14 bps to 39.03% in 2024, then increased by 7 bps to 41.72% in 2025, then advanced by 0 bps to 41.75% in 2026.
- The last three EBT Margin figures came in at 41.75% (Q2 2026), 41.95% (Q1 2026), and 41.72% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 41.75% |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 31.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.75% |
| Mar 31, 2026 | 41.95% |
| Dec 31, 2025 | 41.72% |
| Sep 30, 2025 | 42.22% |
| Jun 30, 2025 | 43.28% |
| Mar 31, 2025 | 26.37% |
| Dec 31, 2024 | 39.03% |
| Sep 30, 2024 | 44.16% |
| Jun 30, 2024 | -128.18% |
| Mar 31, 2024 | 47.54% |
| Dec 31, 2023 | 45.58% |
| Sep 30, 2023 | 47.48% |
| Jun 30, 2023 | 46.59% |
| Mar 31, 2023 | 37.54% |
| Dec 31, 2022 | 46.76% |
| Sep 30, 2022 | 50.40% |
| Jun 30, 2022 | 46.64% |
| Mar 31, 2022 | 45.52% |
| Dec 31, 2021 | 42.02% |
| Sep 30, 2021 | 54.57% |
API Access
Vertex Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();